| Annual Financials | 2015 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
Revenue  | 0 | 2,408 | 2,363 | 2,398 | 2,479 | 3,000 | 3,046 | 3,614 | 3,925 | 3,959 | 4,258 | 4,356 |
| Expenses | 0 | 1,849 | 1,670 | 1,656 | 1,840 | 2,338 | 2,398 | 2,690 | 3,071 | 3,049 | 3,236 | 3,280 |
| EBITDA | 0 | 559 | 693 | 742 | 640 | 663 | 648 | 924 | 854 | 909 | 1,023 | 1,076 |
| Operating Profit % | 0 % | 21 % | 27 % | 29 % | 25 % | 21 % | 20 % | 25 % | 21 % | 22 % | 23 % | 23 % |
| Depreciation | 0 | 53 | 52 | 60 | 52 | 50 | 48 | 48 | 53 | 58 | 57 | 50 |
| Interest | 0 | 6 | 6 | 10 | 5 | 6 | 6 | 6 | 11 | 11 | 27 | 31 |
| Profit Before Tax | 0 | 501 | 636 | 672 | 582 | 607 | 594 | 870 | 790 | 840 | 939 | 996 |
| Tax | 0 | 155 | 213 | 239 | 207 | 188 | 161 | 218 | 214 | 161 | 264 | 292 |
| Net Profit | 0 | 346 | 423 | 433 | 375 | 419 | 433 | 652 | 576 | 678 | 675 | 716 |
| EPS in ₹ | 0.00 | 106.63 | 130.16 | 133.31 | 115.40 | 129.12 | 133.42 | 200.79 | 177.37 | 208.91 | 207.95 | 220.50 |
P&G Hygiene and Health Care
13,459.15
+269.35
(2.04%)
Market Cap
43,689.39 Cr
EPS
207.95
PE Ratio
59.80
Dividend Yield
1.93 %
Industry
Consumer Goods52 Week High
17,745.00
52 Week low
13,150.00
PB Ratio
45.27
Debt to Equity
0.00
Sector
Personal Care
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
| 1,043.40 | 1,06,740.64 | 61.60 | 14,365.10 | 6.53 | -561 | -14.25 | 46.58 | |
| 499.95 | 88,606.89 | 49.07 | 12,886.40 | 7.61 | 1,811 | 1.86 | 44.68 | |
| 2,432.50 | 66,160.51 | 45.76 | 5,757.00 | 9.04 | 1,324 | -2.21 | 39.12 | |
| 13,459.15 | 43,689.39 | 59.80 | 4,258.00 | 7.57 | 675 | 17.34 | 38.90 | |
| 7,888.00 | 25,703.22 | 54.98 | 2,659.20 | 6.40 | 412 | 21.27 | 41.01 | |
| 567.75 | 24,782.29 | 30.25 | 3,624.90 | 4.32 | 724 | 7.06 | 54.67 | |
| 214.50 | 6,967.47 | 89.21 | 1,969.60 | 29.98 | 111 | 0.39 | 43.22 | |
| 160.31 | 2,197.09 | 17.66 | 1,028.80 | 3.10 | 155 | -30.30 | 36.41 | |
| 63.73 | 1,710.23 | 31.86 | 178.30 | 8.65 | 40 | 23.60 | 38.43 | |
| 180.15 | 270.32 | 107.05 | 33.10 | 25.86 | 2 | 42.86 | 50.69 |
Growth Rate
Revenue Growth
7.57 %
Net Income Growth
-0.46 %
Cash Flow Change
-43.02 %
ROE
21.54 %
ROCE
36.07 %
EBITDA Margin (Avg.)
4.53 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 1,948 | 1,948 | 2,166 | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 |
| Fixed Assets | 309 | 309 | 317 | 286 | 250 | 234 | 207 | 184 | 164 | 170 | 139 |
| Current Assets | 1,356 | 1,357 | 1,632 | 603 | 815 | 1,090 | 1,328 | 1,117 | 1,135 | 1,496 | 1,200 |
| Capital Work in Progress | 39 | 39 | 35 | 41 | 22 | 15 | 22 | 38 | 44 | 23 | 28 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1,600 | 1,600 | 1,814 | 834 | 1,154 | 1,368 | 1,600 | 1,411 | 1,475 | 1,945 | 1,692 |
| Total Liabilities | 1,948 | 1,948 | 2,166 | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 |
| Current Liabilities | 599 | 716 | 511 | 582 | 571 | 643 | 595 | 836 | 860 | 1,085 | 981 |
| Non Current Liabilities | 3 | 3 | 4 | 52 | 49 | 66 | 76 | 83 | 85 | 106 | 103 |
| Total Equity | 1,346 | 1,229 | 1,652 | 526 | 806 | 909 | 1,158 | 714 | 738 | 946 | 775 |
| Reserve & Surplus | 1,313 | 1,196 | 1,619 | 494 | 773 | 877 | 1,125 | 682 | 705 | 914 | 742 |
| Share Capital | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 349 | 452 | -964 | 290 | 134 | 358 | -236 | -23 | 339 | -390 |
| Investing Activities | 28 | 221 | 149 | -20 | 34 | 75 | 7 | -27 | -10 | 1 |
| Operating Activities | 426 | 353 | 445 | 416 | 413 | 474 | 863 | 573 | 826 | 471 |
| Financing Activities | -105 | -122 | -1,559 | -106 | -314 | -190 | -1,106 | -569 | -477 | -862 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % | 70.64 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 1.30 % | 1.48 % | 1.57 % | 1.56 % | 1.48 % | 1.43 % |
| DIIs | 13.30 % | 13.30 % | 13.20 % | 13.19 % | 13.60 % | 13.91 % | 14.37 % | 15.28 % | 15.33 % | 15.43 % | 15.44 % | 15.29 % | 15.11 % | 15.16 % | 15.28 % | 15.37 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 10.63 % | 10.58 % | 10.57 % | 10.52 % | 10.43 % | 10.37 % | 10.34 % | 10.22 % | 10.15 % | 10.04 % | 9.90 % | 9.88 % | 9.92 % | 9.87 % | 9.80 % | 9.76 % |
| Others | 5.43 % | 5.48 % | 5.59 % | 5.65 % | 5.32 % | 5.08 % | 4.65 % | 3.87 % | 3.89 % | 3.89 % | 2.72 % | 2.71 % | 2.76 % | 2.77 % | 2.80 % | 2.80 % |
| No of Share Holders | 39,337 | 39,806 | 41,120 | 40,908 | 40,819 | 41,533 | 43,445 | 40,495 | 39,968 | 39,388 | 37,069 | 38,807 | 39,999 | 40,671 | 42,348 | 42,941 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
No dividends have been distributed by the company in the past 10 years
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Integrated Filing (Financial)
Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Hygiene And Health Care Limited (The Company)
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Corporate Action-Board approves Dividend
Unaudited Financial Results For The Quarter Ended December 312024
Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended December 312024 And Interim Dividend 2024-25
Update on board meeting
Corporate Action-Board to consider Dividend
Update On Purpose Of Board Meeting
Intimation Regarding Change Of The Financial Year Of The Company
Intimation regarding Change of the Financial Year of the Company
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Quarter Ended December 312024
Closure of Trading Window
Change In Senior Management Personnel
Change In Senior Management Personnel
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings Of Annual General Meeting
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Business Responsibility and Sustainability Reporting (BRSR)
60Th Annual General Meeting To Be Held On November 26,2024
60Th Annual General Meeting To Be Held On November 26,2024
Reg. 34 (1) Annual Report.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Financial Results For The Quarter Ended September 30,2024
Board Meeting Outcome for Financial Results For The Quarter Ended September 30,2024
Change In Senior Management
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
AGM And Dividend
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Closure of Trading Window
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended September 30, 2024
Announcement under Regulation 30 (LODR)-Dividend Updates
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcement under Regulation 30 (LODR)-Dividend Updates
Annual General Meeting And Payment Of Dividend
Transcript Of Call With Analyst/Investors
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Compliances-Reg.24(A)-Annual Secretarial Compliance
Book Closure -Annual General Meeting And Dividend Payment
Corporate Action-Board approves Dividend
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Year Ended June 30,2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On August 28, 2024
Company Filings to Exchanges
Feb 2025
Technical Indicators
RSI(14)
Neutral 27.67
ATR(14)
Volatile 296.95
STOCH(9,6)
Oversold 18.79
STOCH RSI(14)
Oversold 4.69
MACD(12,26)
Bearish -19.80
ADX(14)
Strong Trend 29.47
UO(9)
Bearish 34.23
ROC(12)
Downtrend But Slowing Down -5.70
WillR(14)
Oversold -96.21
About P&G Hygiene and Health Care
Procter & Gamble Hygiene and Health Care Limited (P&GHHCL) is an Indian company that manufactures and sells branded fast-moving consumer goods in the feminine care and healthcare sectors. The company operates in two segments: healthcare products (ointments, creams, cough drops, and tablets) and hygiene products (feminine hygiene and skin care). Its brand portfolio includes Whisper, Vicks, and Old Spice. P&GHHCL's products are sold through various retail channels including mass merchandisers, grocery stores, club stores, drug stores, department stores, and high-frequency stores. The company has manufacturing facilities in Goa and Baddi, Himachal Pradesh, as well as third-party manufacturing locations across India.
Website
Chairperson NameChittranjan Dua
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
